As Shreehas Tambe, Chief Executive Officer and Managing Director of Biocon Biologics Limited, noted regarding demand and growth potential for GLP-1 therapies, There will be a requirement for significantly higher volumes and Biocons fermentation capability will give us a significant advantage. India leads with a CAGR of 8.4%, driven by a large diabetic population and increasing demand for effective treatments
Add electrolytes on days with diarrhea, heat, or workouts
tirzepatides CV outcomes trial is still running)
Nrf2, a transcription factor that is highly responsive to oxidative stress, serves a key role in mitigating lipid peroxidation and ferroptosis (62)
Drug Design Reviews-Online (Discontinued) (2005) 2:1217
Combating cellular senescence by sirtuins: implications for atherosclerosis